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Abstract
In animals, oxytocin enhances maternal behavior and lowers blood pressure (BP) and negative
affect, while parturitional cocaine disrupts oxytocin activity and increases maternal neglect and
aggression. Thus, we compared oxytocin, BP, maternal behavior, and affect in mothers of infants
who used cocaine (cocaine, n = 10) or did not (no drug, n = 25) during pregnancy. Laboratory BP
and circulating oxytocin, catecholamines, and cortisol were examined before and during a speech
stressor on 2 days, with vs. without prestress baby holding. Ambulatory monitoring assessed BP,
urinary norepinephrine, and cortisol for 24 h at home. The cocaine group had lower oxytocin
levels, greater hostility and depressed mood, less support from others and mastery over life events,
higher BP during all events of testing without the baby, and higher ambulatory BP and urinary
norepinephrine at home, while cortisol and epinephrine responses were blunted. Although they
tended to hold their babies less often at home, baby holding in the laboratory led to decreased BP
in cocaine mothers who then did not differ from no-drug mothers in BP or observed affect.
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1. Introduction
As primary caregivers, mothers who abuse drugs during pregnancy are at high risk for
problems in parenting skills (Lawson & Wilson, 1980). A history of substance abuse has
been associated with poor maternal–infant interactions (Bauman & Dougherty, 1983; Bays,
1990; Howard, Beckwith, Espinosa, & Tyler, 1995; Johnson & Rosen, 1990), as well as
inadequate social support systems and low self-esteem and maternal ego development
(Fineman, Beckwith, Howard, & Espinosa, 1997; Williams-Petersen et al., 1994).
Specifically, maternal cocaine abuse during pregnancy has been correlated with a greater
incidence of maternal neglect (Kelly, Walsh, & Thompson, 1992), problems with maternal–
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infant bonding (Burns, Chethik, Burns, & Clark, 1991), and child abuse in the human
population (Murphy et al., 1991). A relatively recent study found that women who had taken
cocaine during pregnancy had more difficulty interacting with their infants and expressed
subtle hostility during feeding and play periods as compared to nondrug-abusing women
(Goldman-Fraser, 1997).
In an animal model of maternal neglect, it was found that exposure to cocaine in pregnant
rats decreases their subsequent maternal behavior and increases inappropriate and
nonadaptive aggressive behavior. Specifically, rats given a moderate dose of cocaine either
acutely during the postpartum period or chronically during pregnancy display increased
maternal neglect of offspring (less feeding, licking, and nestbuilding) and either compulsive
nonadaptive aggressive behavior (after chronic gestational treatment) or nonprotective
behavior (after acute cocaine postpartum treatment) in the presence of an intruder (Johns et
al., 1998; Johns, Noonan, Zimmerman, Li, & Pedersen, 1994). Continuing exposure to
postpartum cocaine may result in somewhat different patterns of disruptions in maternal
behavior or aggression depending on dose and frequency of use during pregnancy (Johns,
Lubin, Walker, Meter, & Mason, 1997; Johns, Noonan, Zimmerman, Li, & Pedersen, 1997;
Johns et al., 2002; Nelson, Meter, Walker, Ayers, & Johns, 1998). These abnormal maternal
behaviors appeared to be at least partially mediated by cocaine-induced changes in oxytocin
activity (Elliott, Lubin, & Johns, 2001; Johns, Lubin et al., 1997; Lubin, Elliott, Black, &
Johns, 2003).
The neuropeptide, oxytocin, is linked in animal models to both initiation and perhaps early
maintenance of maternal behaviors, including licking and nursing (Champagne & Meaney,
2001; Johns, Lubin et al., 1997; Pedersen, Caldwell, Walker, Ayers, & Mason, 1994), and to
antistress and blood pressure (BP) lowering effects (Knox & Uvnas-Moberg, 1998;
Petersson, Alster, Lundeberg, & Uvnas-Moberg, 1996). Oxytocin administration to female
sheep will induce them to adopt and nurse orphan lambs, demonstrating oxytocin’s role in
maternal–offspring bonding (Keverne & Kendrick, 1992). In rats, exogenous oxytocin or
endogenous oxytocin activity elicited by stroking gives rise to antistress effects [e.g.,
decreases in activity of the hypothalamic–pituitary–adrenal (HPA) axis and BP, but greater
stress analgesia] after repeated administration (Holst, Uvnas-Moberg, & Petersson, 2002;
Petersson, Uvnas-Moberg, Erhardt, & Engberg, 1998; Robinson et al., 2002). Preliminary
evidence from human mothers suggests that oxytocin helps modulate their affective state,
and this may, in turn, influence their stress responses. In mothers who both breast- and
bottle-feed their infants, the act of breast-feeding (which typically elicits greater rises in
plasma oxytocin) is associated with less perceived stress, depression, and anxiety than
bottle-feeding (Heck & de Castro, 1993; Mezzacappa & Katkin, 2002; Modahl & Newton,
1979). Furthermore, women who are breast-feeders also report less anxiety than bottle-
feeding women and show lower BP before and during stress (Altemus et al., 2001;
Mezzacappa & Katkin, 2002; Virden, 1988). However, oxytocin responses of lactating and
nonlactating women do not consistently differ (Altemus et al., 2001), and even among
breast-feeders, there are individual differences in oxytocin responses that directly relate to
affective state. Uvnas-Moberg, Widstrom, Nessen, and Bjorvell (1990) reported that
baseline oxytocin levels in breast-feeding women were lower in those scoring high in
anxiety, aggression, guilt, and suspicion. Our own findings in mothers of infants suggest that
increased BP (both during laboratory and home monitoring) and higher negative affect are
seen in mothers with low plasma oxytocin responsivity (Light, Smith, Johns, Hofheimer, &
Amico, 2001). In this study, oxytocin responses in high responder mothers were enhanced
after 10 min of baby holding, cuddling, and play compared to responses of the same women
when tested on another day after 10 min resting alone without their babies. Similarly, BP
levels at home were lower for an hour after baby holding and nursing in these high oxytocin
responding mothers. Together, these observations suggest that in addition to breast-feeding,
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baby holding and cuddling can increase oxytocin activity in more responsive mothers, and
this may be associated with decreases in BP and more positive mood states. Conversely, low
oxytocin responses may be related to increased BP, negative emotions, and stress sensitivity
in mothers of infants.
Although there is some evidence that cocaine use during pregnancy may be associated with
more negative affect, hostile or aggressive behavior, and maternal neglect, no studies to date
have compared oxytocin responses in mothers who used cocaine during pregnancy vs. those
who did not, nor have any studies addressed the effects of recent baby holding and cuddling
on these mothers. Thus, the present investigation was designed to test the following
hypotheses. (1) Mothers who were (vs. were not) exposed to cocaine during pregnancy show
lower plasma oxytocin levels and reduced oxytocin responses during stress. (2) The cocaine-
exposed mothers also show less maternal behavior at home (decreased time at home spent
holding their baby) and in the laboratory (less positive and more negative affect during baby
holding and play), report greater hostility, depression, anxiety and recent life stress, and
exhibit higher BP, cortisol, and norepinephrine levels both in the laboratory and their home
environments. (3) Stress testing immediately after baby holding and cuddling will be
associated with greater plasma oxytocin responses, lower norepinephrine, and lower BP than
testing without prior baby contact, and these effects will be greater among mothers with no
cocaine exposure during pregnancy.
2. Methods
2.1. Participants
Participants in this study included 25 recent mothers (at least 1 month but not more than 11
months postpartum) who had no history during pregnancy or postpartum of exposure to
cocaine or other substances of abuse, and 10 recent mothers who reported using cocaine at
least once during their pregnancy. All of the cocaine-exposed mothers were recruited
through a local substance abuse rehabilitation and support program for pregnant women,
focusing on intensive prenatal and postnatal care for mothers with substance-abuse
problems. All had been participants for 60 days or longer in this rehabilitation program
which required them to refrain from using cocaine or other substances of abuse, confirmed
by regular urine screens. Thus, our observations should not be influenced by recent drug use.
All of the mothers in the cocaine-exposed group were bottle-feeders; this feeding option was
strongly encouraged by medical and social services personnel to ensure that the infants
would not receive any postnatal substance exposure. To try to recruit no-drug mothers who
were also receiving similar public assistance, we recruited other mothers through a
statewide, county-managed nutrition program, focused on meeting nutritional needs of low-
income mothers and children. However, because the nutrition-program mothers were
strongly encouraged to breast-feed, and none recruited through this agency was a bottle-
feeder, it became necessary to recruit bottle-feeding mothers through special targeted
newspaper ads. Mothers in the no-drug group thus included 14 who breast-fed with
occasional use of expressed breast milk and 11 who exclusively bottle-fed using formula
over the past 30 days. Women who currently used a combination of feeding methods were
excluded from participation.
All research information on substance use or lack of it was derived from phone and in-
person interview questions, not medical records or urine tests. Mothers in both the no-drug
and the cocaine groups were asked during phone screening if they had used any drugs
(prescription, over the counter, or recreational) during or since their pregnancy. Marijuana,
cocaine, and crack were asked about individually after the general question on substance
use. All no-drug mothers stated they had not used any recreational or prescription drugs
during this period, while mothers in the cocaine group all stated that they had used cocaine
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or crack. Participants were also asked about use of alcohol, which a similar number of
mothers in both groups told us they had used, although all use was limited to one drink per
day. Mothers in both groups were asked a second time about any recent use of cocaine or
other recreational drugs other than alcohol when they arrived for screening and testing, and
all denied any use since the baby’s birth. As part of our confidentiality assurance plan
approved by the IRB and the special programs referring these mothers, no effort was made
to question the mothers in any detail about the number of times or amounts of cocaine used
by these mothers during pregnancy. Because all babies were full term and none had low
birthweight or other peri- or postnatal complications, it is assumed that these mothers and
their babies had relatively low drug exposure. In addition, as part of our agreement to ensure
privacy and confidentiality, we did not approach the mothers in either of these programs
ourselves; information sheets describing the study were provided to the staff members who
worked for these programs for them to distribute to potential volunteers at their discretion.
Thus, we have no data on what percentage of those who were eligible agreed to participate,
although we do know that of those mothers who subsequently contacted us and who met
study criteria, over 90% were tested. Moreover, as part of the agreement with the referring
program, mothers from these programs were compensated for participation with vouchers
for purchasing diapers, baby clothing, and other infant care essentials at a local store.
Only mothers of healthy, full-term infants were included, and medical history information
was used to exclude women with average resting SBP and DBP >160/95 mm Hg, or any
other serious cardiovascular, renal, or pulmonary disorder, or current clinical depression or
other psychiatric disorder, or currently using antihypertensive, antidepressant, or other
prescription medications.
2.2. Protocol
Data from the mothers with no prenatal use of drugs has been reported previously, including
details of the protocol and procedures (see Light et al., 2001). In brief, each participant
attended a screening session was fully informed and provided written consent for this IRB-
approved protocol. Then, in a counterbalanced order, each was tested on two consecutive
mornings at the same hour (typically between 9 and 10 a.m.), with one session including a
10-min period of baby contact (holding, reading to, and playing with the baby) and the other
session requiring the mother not to bring the baby to the laboratory and involving a rest-
alone control period instead. In all other ways, the sessions were identical, beginning with
instrumentation with the Accutracker II ambulatory BP monitor (Suntech, Raleigh, NC) to
record BP, then including a 12-min baseline rest, followed by the baby contact or no baby
rest period. Then the baby (if present) was taken from the room by a staff member, and the
mother performed a speech stressor, in which she was tape recorded as she described a
recent event that made her feel angry or stressed. The task began with instructions, followed
by 2 min of silent speech preparation, then 3 min of active speech, followed by 3 min of
listening to replay of the recorded speech, while instructed to relax and recover but also to
think about how effectively she had explained her reasons for feeling angry or upset.
During the 10-min period of baby contact, mothers and infants were videotaped first as they
interacted in response to the instruction “hold and play with your baby as you normally do,”
and then in a more structured form of play involving a picture book (The Little Book of Hugs
by S. Weisinger), depicting children being hugged in different ways with simple text (e.g.,
“There are daddy hugs.” “There are grandma hugs.”). These videotapes were replayed and
rated by a single blind rater using the ‘modified frequency’ sampling method, coding every
6 s of the tape for the presence or absence of the following behaviors (Martin & Bateson,
1993). The mothers’ positive and negative affective behaviors included the following: smile,
laugh, frown, kiss, eye contact with baby, talk positive, talk negative, talk neutral, and baby
maintenance (diaper check or change, burp, give pacifier, or other sucking item, etc.).
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Because of wide disparities across infants in their stages of development due to age, the
babies’ behaviors that were recorded included only two: crying and laughing. Because
educational differences may have affected responses during the book reading, only
responses during first 3 min of the holding and free play were analyzed; thus, the possible
range of scores for each behavior are from 0 (never present) to 30 (present in every 6-s
interval).
For the day spent at home between the two test sessions, the mothers continued to wear the
ambulatory BP monitor, programmed to take readings 4 times/h prior to bedtime and 2
times/h during sleep. For each reading, the mother recorded her activities, indicating
whether she had nursed, bottle-fed, or held the baby since the last reading. For purposes of
analysis, readings were grouped into sleep, postfeeding (including all readings during and up
to 60 min after breast- or bottle-feeding), and all other waking activities. Mothers also
collected a 24-h urine sample for this same day between sessions, which was measured and
aliquotted for determination of 24-h urinary norepinephrine and cortisol levels. Compliance
with the 24-h urine collection was ascertained using race- and gender-specific normal ranges
for 24-h creatinine clearance.
2.3. Cardiovascular, urine, and blood sampling
BP measurements were obtained during Min 2, 4, 6, 8, 10, and 12 of the resting baseline and
during Min 1 and 3 of the preparation, active speech, and replay/recovery periods. Any
reading affected by movement artifact was deleted. Mean baseline levels were defined as the
average of all six samples obtained during that period.
Blood samples were obtained for plasma oxytocin and plasma catecholamine levels at the
end of baseline and during Min 2 of active speech. The samples were drawn into chilled
tubes containing sodium heparin, kept on ice, and cold centrifuged to separate plasma within
a few minutes after collection. Plasma was rapidly frozen and maintained at −80 °C until
assayed. Serum was also obtained at baseline only for determination of serum cortisol. This
sample was drawn into a tube, allowed to clot for 30 min, then separated serum was likewise
frozen at −80 °C until assayed.
Oxytocin was first extracted from plasma and then assayed using a specific oxytocin
antibody (Pittsburgh Antibody 2) by Dr. Janet Amico of the University of Pittsburgh
following previously published techniques (Amico et al., 1985; Amico, Johnston, &
Vagnucci, 1994). The standard curve was linear between 0.5 and 10 pg/tube, and any sample
less than 0.5 pg was designated as zero. Intra- and interassay coefficients of variation were
6.5% and 8% respectively; results are reported corrected for recovery (which is 75 ± 3%).
Plasma epinephrine and norepinephrine as well as 24-h urinary norepinephrine levels were
determined using high-performance liquid chromatography (HPLC) methods, while serum
cortisol and 24-h urinary cortisol levels were determined using radioimmunoassay (RIA)
kits commercially available from ICN Biomedical. All assays were performed by trained
technicians at the UNC General Clinical Research Center as previously described (Girdler et
al., 2003; Koo-Loeb, Costello, Light, & Girdler, 2000).
Because pretests demonstrated that oxytocin, cortisol, and catecholamine responses from the
baseline blood sample drawn on the first day were higher than on the second day, probably
due to greater anxiety on the first test day, a single baseline sample averaged across both
days was used in all analyses to represent resting levels.
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2.4. Affect and perceived life stress assessments
At home prior to testing, participants completed a set of questionnaires focusing on affect
and life stress. These included the Beck Depression Inventory (BDI; Beck, Ward,
Mendelson, Mock, & Erbaugh, 1961), a hostility scale consisting of the 15 items (Ho-15)
that make up the hostile affect, aggressive responding, and cynical hostility subscales of the
27-item Cook Medley Hostility Scale (Barefoot, Dodge, Peterson, Dahlstrom, & Williams,
1989; Barefoot, Larsen, von der Lieth, & Schroll, 1995; Beckham, Calhoun, Glenn, &
Barefoot, 2002; Cook & Medley, 1954), the Anger Expression Inventory (AX; Spielberger
& Syderman, 1994), the Interpersonal Support Evaluation List (ISEL; Brookings & Bolton,
1988; Cohen, 1985), the Pearlin Mastery Scale (Goldenberg et al., 1997; Skaff, Pearlin, &
Mullan, 1996), and to assess stress over the past month, the Perceived Stress Scale (Cohen,
Kamarck, & Mermelstein, 1983). On the day of the ambulatory monitoring, they also
completed the state and trait subscales of the State–Trait Anxiety Index (STAI; Spielberger,
1983) and, to assess that day’s stress, the Daily Stress Inventory (Brantley, Waggoner,
Jones, & Rappaport, 1987).
2.5. Data analysis
Demographic information on the mothers is depicted in Table 1. Cocaine and no-drug
groups did not differ in mothers’ age, body mass index, number of hours spent sleeping on
the ambulatory monitoring day, or current use of alcoholic beverages, but did differ in racial
distribution (80% vs. 31% black, P < .005), feeding method (P < .001), and education (50%
vs. 100% ≥ high-school completion, P < .001), and despite similarities in the range of baby
ages included in both groups, they were marginally different in mean baby age (3.5 vs. 5.5
months, P < .10). For all physiological variables involving repeated measurement (effect of
baby vs. no baby day for laboratory BP, oxytocin and catecholamine measures, and effect of
activity for the ambulatory BP measures), initial analyses using repeated-measures analyses
of variance (ANOVAs; PROC GLM, SAS Institutes, Cary, NC) preceded all examinations
of univariate analyses to compensate for the increased likelihood of obtaining false positives
that may be associated with multiple comparisons. Only when a main effect of group or
group × time period interaction was obtained were univariate analyses examined. In the
primary analyses comparing all no-drug vs. cocaine-exposed mothers, feeding method, race,
education, and baby age were employed in initial models as covariates, but were retained in
final models only when significant. In secondary post hoc analyses separating the no-drug
mothers into breast-feeders vs. bottle-feeders, these two groups were compared with each
other, as well as being separately compared with the cocaine group. Final contrasts were
performed using least-squares means, and this was the primary analysis method for the
videotape behavior ratings. Correlations among the multiple measures were examined using
simple regression. Unless otherwise indicated, all tests were two-tailed and α was set at P < .
05.
3. Results
3.1. BP responses in the lab
Repeated-measures ANOVAs yielded significant interaction effects of group × baby vs. no
baby day for DBP, F(1,34) = 4.62, P ≤ .04, and marginally significant interaction effects for
SBP, F(1,34) = 3.74, P ≤ .06. Thus, simple effects analyses were performed, comparing
SBP and DBP responses between the two groups on each day separately, and also looking
within each group for BP differences between the two test days.
On the no baby day, the cocaine-exposed mothers showed higher overall BP levels
compared to the no-drug mothers (see Figs. 1 and 2). The cocaine group showed
significantly higher DBP at baseline than the no-drug group (74.0 vs. 67.3, P < .026) as well
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as marginally higher SBP at baseline (110.3 vs. 103.6, P < .075). These group differences
were maintained or even enhanced during speech preparation (SBP: 118.7 vs. 108.8, P < .
034; DBP: 79.5 vs. 71.8, P < .007) and postspeech recovery (SBP: 120.1 vs. 109.9, P < .
039; DBP: 78.9 vs. 71.8, P < .066) on the no baby day. Differences during active speech
were small and did not approach significance.
On the baby contact day, these group differences in BP were no longer present. When the
cocaine mothers brought their infants to the study and held and played with them, their BP
levels were reduced to levels similar to those of the no-drug mothers and the two groups no
longer differed significantly (see Figs. 1 and 2). Most importantly, simple effects analyses
comparing SBP and DBP over days within each group separately showed that the cocaine
group demonstrated lower DBP across all events on the baby contact day than they showed
on the no baby day (P < .05 at baseline and during speech preparation, P=.07 during active
speech and replay), while the no-drug group did not differ significantly in their DBP
responses between the 2 days. For SBP, the difference between the baby and no baby days
was not significant for the cocaine group but was directionally consistent with the DBP
difference, while for the no-drug group, there was a nonsignificant trend toward higher, not
lower, baseline SBP and DBP on the baby contact day. Thus, this finding indicates that,
contrary to a priori hypotheses, the manipulation of 10 min of warm mother–infant contact
was associated with beneficial reductions in BP specifically in the cocaine-exposed mothers,
an effect that persisted throughout the session during both high-and low-stress activities.
Including feeding method, race, education, and baby age as covariates in these models did
not alter these results substantially, and in no case were these covariates significant.
Furthermore, post hoc analyses separating the no-drug breast-feeding and no-drug bottle-
feeding mothers into two subgroups failed to yield even trends toward differences in any
laboratory BP measure between these two no-drug subgroups (all Ps>.20). Other post hoc
analyses restricting comparisons to the 10 cocaine-exposed mothers vs. the 11 no-drug
bottle-feeding mothers yielded the same direction and approximate magnitude of differences
on the no baby day for all significant group differences obtained in the initial analyses,
although there was a loss of statistical power with the reduced sample size (baseline
110.3/74.0 vs. 105.3/68.0, P < .15; speech preparation 118.7/79.5 vs. 110.2/71.5, P < .03;
replay 120.0/79.5 vs. 109.2/72.9, P < .07, respectively). As with the original analyses, no
group differences in BP were significant on the baby day. Altogether, these post hoc
analyses generated no support for the interpretation that differences in laboratory BP
between the cocaine and no-drug groups were due to breast-feeding, or to group differences
in baby age, mother’s education, or race.
3.2. Plasma oxytocin
In contrast to laboratory BP differences, group differences in oxytocin were present on the
baby contact day as well as the no baby day; the main effect of group was significant during
the 2-day combined baseline and during speech on both days, Fs(1,34) = 8.8, 14.6, and 23.1,
Ps < .0055, .0005, and .0001. As predicted, the cocaine-exposed mothers showed lower
plasma oxytocin levels than the no-drug mothers at baseline (1.1 ± 0.2 vs. 2.0 ± 0.2 pg/ml, P
< .0055). During the speech task on both the baby and no baby days, after adjustment for
baseline differences, the cocaine group showed slight but significant decreases from their
already low baseline levels (−0.7 ± 0.3 and −0.6 ± 0.1 pg/ml, respectively, P < .025) while
the no-drug mothers showed no reliable changes ( + 0.3 ± 0.2 and 0 ± 0.1 pg/ml,
respectively); thus, the responses to stress further exaggerated the oxytocin differences
between the groups, Fs = 7.8 and 11.0, Ps < .009 and .002; see Fig. 3).
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3.3. Behavior during baby contact in the laboratory
Episodes of baby crying were rare among the no-drug group when the mother was playing
with and holding the baby (mean 0.5 ± 0.7, difference from zero, P = NS) but more frequent
in the cocaine group (mean 2.4 ± 1.0, difference from zero, P ≤ .026). Probably for this
reason, mothers in the cocaine group spent more of the baby holding and play time on baby
diaper checks, changing, burping, and other maintenance activities (8.3 ± 2.0 vs. 0.8 ± 1.3, P
≤ .03). In terms of positive and negative maternal affective behaviors, mothers in the
cocaine-exposed group laughed more often during baby play (4.4 ± 0.9 vs. 1.1 ± 0.5, P ≤ .
003) and smiled nearly as often (4.9 ± 2.0 vs. 7.5 ± 1.3, P = NS) than those in the no-drug
group. No group differences were obtained for mother frowning, kissing baby, eye contact,
or for positive, neutral, or negative speech. Thus, overt signs of positive affect were as high
or higher, and signs of negative affect were as low in the cocaine-exposed as in the no-drug
mothers during baby play and holding.
3.4. Twenty-four-hour BP and contact with baby at home
For the 24-h period between the first and second laboratory sessions, all mothers continued
to wear the ambulatory BP monitor and to collect all urine for norepinephrine and cortisol
measures. Except during sleep, each time the monitor took a reading (four times per waking
hour), the mother recorded her current activity and whether she had been holding or feeding
her baby at any time since the last reading. The number of readings during and up to 1 h
after feeding their babies did not differ reliably between the cocaine-exposed and no-drug
groups after controlling for baby age (5.0 ± 1.5 vs. 6.7 ± 0.9, P = NS). However, consistent
with a priori hypotheses, there was a trend for mothers in the cocaine group to have fewer
times that they held their babies when not feeding them (7.7 ± 2.1 vs. 11.2 ± 1.2, P ≤ .08
one-tailed).
Lack of adequate sleep was considered as a potential confounder in these analyses.
However, the cocaine and no-drug groups did not differ in hours of overnight sleep on the
ambulatory monitoring day, and both groups achieved normal sleep durations (8.6 ± 0.6 vs.
7.9 ± 0.4 h, P>.25). In addition, duration of sleep was not correlated with baby age, or with
depression, anxiety, or hostility scores (all rs ≤ +.10, Ps = NS). Thus, no correction for
differences in sleep duration was deemed necessary.
Mean SBP and DBP levels for sleep, postfeeding (including up to 60 min after nursing or
bottle-feeding), and all nonfeeding waking activities depicted for the cocaine group (all
bottle-feeders) and for the no-drug mothers subgrouped into breast-feeding and bottle-
feeding mothers are shown in Figs. 4 and 5. Because feeding method was a significant
covariate only for the postfeeding SBP measure, F(1,30) = 3.86, P < .05, and postfeeding
SBP was the only BP measure marginally different between the breast- and bottle-feeding
subgroups of no-drug mothers, analyses for ambulatory SBP measures were performed two
ways: (1) like all the other analyses in this study, comparing the cocaine group with the
combined no-drug group, and (2) for postfeeding SBP only, comparing the cocaine group
with the two no-drug subgroups divided by feeding method. In the two-group analysis,
repeated-measures ANOVAs yielded a significant main effect for group across the three
activity categories for both ambulatory SBP and DBP, F(1,31) = 9.05 and 4.47, Ps ≤ .005
and .043, respectively, reflecting the consistently higher BP level of the cocaine group vs.
the combined no-drug group. In the added three-group analysis for postfeeding SBP, the
group effect remained significant, F(2,30) = 8.53, P < .0012. Breast-feeding no-drug
mothers had marginally lower postfeeding SBP levels than bottle-feeding no-drug mothers
(107.6 ± 2.0 vs. 113.7 ± 2.3, P < .056) and both of these subgroups had lower postfeeding
SBP levels than the cocaine group (120.6 ± 2.5, Ps < .0003 and .05, respectively.
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3.5. Norepinephrine, epinephrine and cortisol measures in laboratory and at home
Groups did not differ in their plasma norepinephrine levels at baseline or during stress on
either laboratory day, when all participants performed the same activities. However, in the
home environment where individual differences in behavior and emotional reactions
naturally occurred, the cocaine group had higher 24-h urinary norepinephrine levels than the
no-drug group [45.3 ± 6.2 vs. 29.9 ± 3.7 mg/24 h, F(1,33) = 4.48, P ≤ .04]. Urinary
norepinephrine levels of no-drug breast- and bottle-feeders were not different (30.7 ± 4.9 vs.
28.9 ± 5.7 mg/ 24 h, P>.80), and the cocaine group differed from both, confirming that the
enhanced norepinephrine activity at home was not due to feeding method.
Although their baseline plasma epinephrine levels were similar to the no-drug group (40.8 ±
19.2 vs. 37.2 ± 8.4 pg/ml, P = NS), the cocaine group showed a blunted epinephrine
response to stress on both days after covarying for baseline levels. The no-drug group
demonstrated epinephrine increases above baseline levels during stress on both the baby and
no baby days (+ 30.6 and + 21.5 pg/ml, P < .026 and .08) while the cocaine group showed
epinephrine decreases, not increases, during stress on both days (−19.3 and −15.9 pg/ml).
The cocaine group showed a trend towards lower serum cortisol levels at baseline than the
no-drug group; however, this difference was specifically vs. the no-drug breast-feeders (3.89
± 1.5 vs. 6.37 ± 1.5 pg/ml, P < .028), while they did not differ from the no-drug bottle-
feeders (4.68 ± 1.8, P = NS). In contrast, their 24-h urinary cortisol levels were lower than
the no-drug bottle-feeding subgroup (49.0 ± 15.0 vs. 76.5 ± 18.0 mg/24 h, P ≤ .027), while
not differing from the breast-feeding mothers (52.0 ± 15.9, P = NS). Together, these
findings suggest that cortisol may be modestly altered in this group, but might best be
described as low–normal.
3.6. Negative affect, social support, stress, and mastery measures
As depicted in Table 2, the cocaine group reported higher levels of negative affect and
recent stress along with lower levels of social support and control over their lives compared
to the no-drug group. Most notably, the cocaine mothers scored higher than no-drug mothers
in both total hostility (sum of the 15 items in the hostile affect, aggressive responding, and
cynical hostility Ho subscales) and in depressive symptoms on the BDI, Fs(1,34) = 4.01 and
7.58, Ps ≤ .05 and .01, respectively. The cocaine group scored lower on the Pearlin Mastery
Scale and on the ISEL total social support score, Fs = 10.58 and 4.61, Ps ≤ .003 and .04,
respectively. They also tended to report more life stress on the Perceived Stress Scale
(reflecting perception of total stress exposure and sense of being overwhelmed during the
past 30 days) and higher state anxiety on the ambulatory monitoring day, Fs = 3.01 and
3.12, P ≤ .09. No significant group differences were seen in terms of the Anger Expression
Scale, the Daily Stress Inventory (hassles and stressors reported for the 24-h period of home
monitoring), or Trait Anxiety. Altogether, this profile suggests a pattern of more aggressive
responding and negative mood combined with higher stress exposure in recent weeks and
less stress buffering from feeling in control over their lives or from emotional and tangible
support provided by family and friends.
3.7. Interrelationships between oxytocin and other outcome measures
Based on directional hypotheses, we also examined simple correlations between oxytocin
levels and other outcome measures, specifically BP measures and measures of stress and
stress buffers, in the sample as a whole (N = 35; see Table 3). Oxytocin level at baseline was
unrelated to any BP measure, but higher oxytocin during speech stress on the baby contact
day was related to lower ambulatory SBP after baby feeding, to lower laboratory SBP at
speech preparation on the baby contact day (the period immediately after baby contact), and
to lower laboratory DBP at baseline on the baby contact day (r = −0.32, −0.29, and −0.30,
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respectively, P < .05). Oxytocin levels at baseline and during speech were both positively
correlated with higher Pearlin Mastery Scale scores (r= + 0.39 and + 0.33) and with greater
total social support scores on the ISEL (r= + 0.29 and + 0.40, respectively, P < .05).
Relationships with other affective and stress measures were in the predicted directions but
nonsignificant (see Table 3).
In contrast to oxytocin, lower serum cortisol was associated only with increased state
anxiety (r = −0.42, P < .029), but not to other psychological measures (Ps ≥ .20). Higher
plasma norepinephrine at baseline and during stress was linked to higher depression scores
(rs= + 0.31 and + 0.35, Ps < .05) but not to other measures (Ps ≥ .20). Urinary cortisol and
norepinephrine both showed no reliable associations with any of these indexes of
psychological distress (Ps ≥ .13).
4. Discussion
A consistent pattern of parallels was observed between the responses of mothers in this
study who used cocaine during their pregnancy and animal models of gestational cocaine
exposure. In animal models, gestational cocaine exposure leads to deficits in oxytocinergic
activity, and to diminished maternal but increased aggressive behaviors, effects similar to
those seen in dams treated centrally with an oxytocin antagonist rather than cocaine (Johns,
Lubin et al., 1997; Johns, Noonan et al., 1997, Johns et al., 1998; Lubin, Elliott et al., 2003).
In the present investigation, mothers with gestational cocaine exposure reported more
hostility and depressed mood, a trend towards more life stress over the past month, and less
social support and sense of mastery and control in their lives. These mothers tended to hold
their babies less frequently over a 24-h period in their home environments, a day when they
showed greater production of the stress hormone, norepinephrine, and higher BP across all
activities, both asleep and awake, compared with other mothers of infants. Consistent with a
priori hypotheses, all of these differences were linked in the cocaine group with lower
plasma levels of oxytocin and diminished oxytocin responses to mental stress in the
laboratory. In the total sample of 35 mothers studied, higher oxytocin levels at baseline and
during stress were correlated with greater social support from others and with greater sense
of control over events in their lives.
The central oxytocinergic system influences many areas of the brain involved in both
emotion and cardiovascular control, in addition to its own actions on oxytocin receptors in
the periphery that can directly modulate BP and other cardiovascular measures. Recent
studies in oxytocin knockout mice have confirmed that these animals have abnormal
autonomic and baroreflex control over heart rate (HR) and BP, and that female mice lacking
oxytocin have increased anxiety-like behaviors (Mantella, Vollmer, Li, & Amico, 2003;
Michelini, Marcelo, Amico, & Morris, 2003). Other recent research in both male and female
animal models indicates that in addition to its production within the hypothalamus, oxytocin
is produced and released in the heart and the vasculature, and that oxytocin specifically
activates receptors that are present in both sites, leading to decreases in HR, contractile force
and vascular resistance (Jankowski et al., 2000; Mukaddam-Daher, Yin, Roy, Gutkowska, &
Cardinal, 2001; Thibonnier et al., 1999). Thus, oxytocin may act both centrally and
peripherally to lower BP. Although the present study is correlational in nature, and no cause-
and-effect conclusions can be drawn, the direction of the oxytocin and BP effects are
consistent with the possible contribution of low oxytocinergic activity to the increased BP in
the cocaine-exposed mothers.
In addition to their deficient oxytocin activity, the cocaine-exposed mothers demonstrated
other alterations in neuromodulating systems: excessive 24-h urinary norepinephrine levels
combined with low–normal serum and urinary cortisol levels. The heightened
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norepinephrine levels may be linked to increased stress exposure and decreased coping
resources, as suggested by their psychosocial ratings, but increased central adrenergic
activity can also directly contribute to both increased BP and negative affective states, such
as anxiety, depression, and hostility, all of which were seen in this group. Depressive
symptoms have also been correlated with suppressed baseline cortisol but enhanced cortisol
and ACTH increases during cocaine administration to dependent individuals, suggesting that
for some individuals, depressive symptoms linked to altered HPA axis activity may precede
and be temporarily alleviated by cocaine use (Elman et al., 1999). Although it is not possible
in the present study to determine whether the greater depressive and anxiety symptoms in
the cocaine-exposed mothers preceded and enhanced vulnerability to cocaine abuse, prior
research by Abraham and Fava (1999) used blinded retrospective histories to examine
whether substance abuse or depression came first in patients with a history of both. They
found that patients with a history of cocaine abuse had more lifetime episodes of depression
(mean 12.2 episodes) compared to patients who had abused other drugs, particularly opiates
(mean 3.7 episodes), and that the depressive episodes began a number of years before their
cocaine use. These observations are consistent with the theory that cocaine use may in some
cases begin as part of an effort at self-medication for depressive and anxiety symptoms. Our
study’s findings of milder psychological symptoms that were linked to blunted cortisol but
increased norepinephrine levels suggest that such residual markers may persist even during
abstinence and recovery. It must be emphasized that, in the present study, any mother
currently using antidepressants or meeting diagnostic criteria for clinical depression was
excluded.
There are a number of limitations to this investigation and the findings must therefore be
generalized only with caution. First and most important, the subgroup with cocaine exposure
during pregnancy was small and highly selected; all of them were enrolled in a rehabilitation
program while pregnant, and had full-term, uncomplicated deliveries, and all were not
currently depressed or on antidepressants. Thus, our sample may be representative of only
the less affected part of this population. Haller, Miles, and Dawson (2003) compared
pregnant substance abusers who enrolled in a similar program (n = 102) vs. the minority
who declined such treatment (n = 23) in a sample much like ours from the southeastern
United States where the majority were unemployed African Americans with no college
education. They found no group differences in these demographic variables, but reported
that women who enrolled in treatment had greater drug severity, emotional distress,
depression, and other psychological symptoms than those who did not, a profile similar to
the cocaine-exposed participants in our study. Nevertheless, these women did make up
approximately 80% of the pregnant substance abusers they screened, suggesting that our
findings may apply to the majority of women in this group. Second, the present study is
essentially correlational in nature and no definitive evidence can be provided that oxytocin
deficits are a major or even a minor contributing cause of the higher BP or greater hostility,
anxiety, and depressive symptoms in the cocaine-exposed group. BP differences between the
two groups might plausibly be due to many other variables, such as direct and indirect
residual effects of that period of prior drug use (including poorer diet, sleep, and exercise
patterns) and long-term environmental stress exposure. All mothers in the cocaine-exposed
group, however, had no recent exposure to drugs as confirmed by their statements and by
urine screens required by their rehabilitation program, so that direct effects of cocaine on BP
are unlikely to be the source of our group difference. The majority of recent investigations
have indicated that although cocaine can increase BP and circulating catecholamines
transiently in a dose-dependent fashion, these elevations normalize within 24 h after most
recent use, after which age-adjusted BP levels of cocaine users do not differ from those of
nonusers (Brecklin & Bauman, 1999; Brecklin et al., 1998; Foltin, Ward, Haney, Hart, &
Collins, 2003; Sofuoglu, Nelson, Babb, & Hatsukami, 2001). Stress exposure and lifestyle
differences provide potentially important contributions to our findings. Although they did
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not report greater exposure to stressors on the day of ambulatory monitoring, mothers in the
cocaine-exposed group did report less control over the stressful events they experienced in
the past month (based on the Perceived Stress and Mastery Scales) and less access to social
support to buffer against the effects of high stress. According to Seeman, Singer, Ryff,
Dienberg-Love, and Levy-Sorms (2002); this combination is one that frequently leads to
greater total allostatic load with significant implications for higher BP and depressive
symptoms, and other health outcomes. Thus, within the present design, it is not possible to
separate these factors from oxytocin’s influence on the BP and affect differences observed.
The range of infant ages within this sample, from age 1 month to 11 months, represents a
period of dramatic changes in behavioral development for the infant, in experience with
parenting skills for the mother, and in attachment and bonding for the mother–infant dyad. A
more restricted age range would have been preferable to reduce error variance; however,
both the cocaine and the no-drug groups included infants near the upper and lower ends of
this age range, and adjustment for infant age in no case affected our group differences. This
wide age range was a factor in our decision to limit our infant behavior and mother–infant
interaction assessments to very few measures, although such dyadic interactions deserve
greater attention in future, larger scale studies. Clearly, it would also have been better to
have had both groups matched for feeding method, particularly because the act of breast-
feeding typically involves a surge in oxytocin activity. The fact that all of the cocaine group
elected to bottle-feed rather than breast-feed was in fact a sign of their compliance with
medical advice, which was directed at protection of the infant, whereas in the no-drug group,
most women who chose bottle-feeding did so against the weight of medical advice. As both
primary and secondary analyses demonstrated, feeding method, education, and racial group
differences did not account for the overall pattern of group differences obtained. Even in the
case of the exception to this overall pattern, postfeeding SBP, the cocaine group maintained
higher BP levels than either the bottle- or breast-feeding no-drug mothers.
Although the pattern of differences in the cocaine-exposed mothers is consistently in the
direction suggesting increased stress and heightened sympathetic nervous system activity,
more negative affect and less warm baby contact, the laboratory data on BP offered some
more positive signs. That is, on the day when all mothers held and played with their babies
for 10 min prior to stress exposure in the laboratory, the cocaine-exposed group no longer
had higher BP than the comparison group of mothers. In fact, their BP levels were
significantly reduced relative to their own levels on the day when they had no baby contact
time. This observation suggests that although their oxytocinergic pathways may be less
responsive than other mothers, the cocaine-exposed mothers appear to benefit when
encouraged to spend warm contact time with their infants. Given the pharmacological
properties of cocaine, such contact may be acting through other mediators that we did not
assess directly, such as endogenous opioids, serotonergic systems, or via altered autonomic
balance. A recent animal publication does indicate that some alterations in the serotonergic
and dopaminergic systems are seen in specific brain regions at the time when aggression is
increased by gestational cocaine treatment, although the relevance of such changes are
presently unknown (Lubin, Cannon, Black, Brown, & Johns, 2003). Alternatively, they may
demonstrate an increase in oxytocin activity that was not detected given the short half life of
oxytocin in plasma and the timing of our blood sampling. It was also notable that in the
laboratory, when instructed to hold and play with their babies, the cocaine-exposed mothers
showed equal or greater positive affective behaviors and no excessive negative affective
behaviors compared to the no-drug mothers, although their babies cried more often; greater
crying and irritability in infants prenatally exposed to cocaine has been reported as typical
(Keller & Snyder-Keller, 2000). This positive affect when interacting with their infants in
the laboratory is in contrast to the questionnaire data describing the mothers’ typical
affective states, in which the cocaine group reported greater hostility and depressed mood. It
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is possible that the baby serves as a security or transitional object to these mothers, a signal
of the positive changes that they have begun to make in their lives. In addition, the
significance of warm touch with their infants may be especially powerful for this group of
mothers, especially if they rarely receive warm touch contact or emotional support from
others, as suggested by their low social-support scores. One possible interpretation is that if
the cocaine-exposed mothers could have more warm physical contact time with their infants
at home, they might benefit by improving their own mood and their BP levels.
Although the mothers did show benefit from baby contact in the laboratory setting, their
diaries indicated that the cocaine-exposed mothers held and played with their babies
somewhat less frequently at home than the other mothers. This may explain why the
ambulatory home BP differences between the groups were more similar to the BP
differences observed in the laboratory on the day of no baby contact. It might have been
interesting to assess whether the mothers would have interacted with their babies in the
laboratory if given a choice rather than following the study protocol. These observations
suggest that the mothers may need encouragement and even direct training and practice in
holding, touching, and making warm contact with their babies. Extended physical contact
between mother and infant has been shown previously to have significant health- and
growth-enhancing benefits for the infant, especially if premature or with other health
problems at birth (Chwo et al., 2002). Some of these studies have also demonstrated that
extended mother–child contact has benefits for the mother and father as well, decreasing
negative affect and perceived stress, and increasing sensitive maternal/paternal behavior
(Feldman, Eidelman, Sirota, & Weller, 2002).
Reports of poor parenting patterns and increased antisocial and physically aggressive
behaviors among current and former cocaine users have encouraged further study aimed at
focusing on factors involved in mediating these behaviors and on designing interventions to
replace such behaviors with more positive ones. Recent work by Hien and Miele (2003)
documented excessive use of emotion-focused coping and pointed to the importance of
emotion regulation in the prevention of violence in drug-abusing women. Coyer (2003)
interviewed women recovering from cocaine addiction about parenting, and reported that
major themes included inability to control impatience and anger as well as the mother’s own
exposure as a child to poor or absent parenting (based on abandonment and/or a
dysfunctional family). Animal studies have shown a critical link between early life
experience, later maternal behavior, and oxytocin. Mother rats that have higher rates of
maternal behavior (licking and grooming their pups) than other dams also have markedly
higher oxytocin receptor density in the amygdala (Champagne & Meaney, 2001).
Significantly lower oxytocin levels are found in the amygdala during the postpartum period
when rat mothers gestationally treated with cocaine are compulsively aggressive and
aggression is significantly elevated in nontreated rat mothers when amygdaloid oxytocin
receptors are blocked during the postpartum period (Johns et al., 1998; Lubin, Elliott et al.,
2003). Increases in oxytocin levels in brain regions of the postpartum rat, such as the medial
preoptic area of the hypothalamus, ventral tegmental region, and amygdala, are associated
with better maternal behavior and, for amygdala only, decreased aggression (Elliott et al.,
2001; Johns et al., 1998). These data suggest that increasing oxytocin levels and binding
during the postpartum period by some means (perhaps contact) may enhance different
aspects of maternal behavior. Interestingly, high rates of maternal behavior can be also be
enhanced by selective breeding, suggesting a genetic basis, but cross-fostering and other
interventions have confirmed that when the female pups mature, they will demonstrate
maternal behaviors that replicate their early experience (prenatal and rearing), not their
genetic background. This transgenerational effect makes it doubly important that efforts be
made to encourage former cocaine-exposed mothers to increase (and model) good parenting
behaviors (Champagne & Meaney, 2001; Johns et al., 2002). Stronger bonding with their
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own children as well as enhanced psychoemotional state are both important components to
address in future, larger scale research (particularly intervention studies) involving this
population. This and prior investigations indicate a role for warm physical contact and
oxytocin within such research, for which the present study represents only an encouraging
first step.
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Differences in laboratory systolic blood pressure (SBP) levels during baseline, speech
preparation, active speech, and recovery periods on the baby contact vs. the no baby test
days for the cocaine-exposed vs. no-drug groups. Cocaine group SBP>no-drug group SBP
for baseline, preparation, and recovery on the no baby day, Ps < .075, .034, and .039,
respectively, but during speech on both days and during all events on the baby day, all Ps =
NS; effect sizes for group differences on the no baby vs. baby days are 0.10 vs. 0.02 for
baseline, 0.14 vs. 0.02 for preparation, 0 vs. 0.01 for speech, and 0.14 vs. 0.08 for recovery.
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Differences in laboratory diastolic blood pressure (DBP) levels during baseline, speech
preparation, active speech, and recovery periods on the baby contact vs. the no baby test
days for the cocaine-exposed vs. no-drug groups. Cocaine group DBP>no-drug group DBP
for baseline, preparation, and recovery on the no baby day, Ps < .026, .007, and .066,
respectively, but during speech on both days and during all events on the baby day, all Ps =
NS; effect sizes for group differences on the no baby vs. baby days are 0.16 vs. 0 for
baseline, 0.24 vs. 0.01 for preparation, 0 vs. 0.01 for speech, and 0.14 vs. 0 for recovery. In
addition, for the cocaine group only, DBP levels on the no baby day are higher than on the
baby day, P < .05 for preparation and recovery, P < .07 for baseline and speech.
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Plasma oxytocin levels during single combined baseline and during speech on both the baby
contact and no baby test days are lower for the cocaine-exposed vs. no-drug groups.
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Mean ambulatory levels of SBP during sleep, postfeeding, and all other waking activities are
higher for the cocaine vs. the no-drug group (breast-feeding + bottle-feeding mothers
combined), P < .005.
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Mean ambulatory levels of DBP during sleep, postfeeding, and all other waking activities
are higher for the cocaine vs. the no-drug group (breast-feeding + bottle-feeding mothers
combined), P < .05.
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Table 1
Demographic information on cocaine vs. no-drug groups
Variable Cocaine No drug Difference P
n 10 25
Mother age (years) 30.2 ± 1.5 29.0 ± 1.1 NS
Baby age (months)a 3.5 ± 1.2 5.5 ± 0.5 P < .10
 Range 1–11 2–11
Ambulatory sleep (h) 8.6 ± 0.6 7.9 ± 0.4 NS
Body mass index (kg/m2) 27.5 ± 1.6 25.0 ± 1.1 NS
Alcohol beverage/day 0.3 ± 0.1 0.4 ± 0.1 NS
 Range 0–1 0–1
Breast-feed/bottle-feeda 0:10 14:11 P < .001
Black/Whitea 8:2 7:18 P < .005
Percentage with no current spouse/partner 40 25 NS
Percentage who are high-school graduatesa 50 100 P < .001
NS = nonsignificant (P>.10).
a
Subsequent analyses performed after covarying for these variables, unless covariate found to be nonsignificant.
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Table 3
Oxytocin level during stress after baby contact: correlations with blood pressure and psychosocial measures in
the full sample (N = 35)
SBP DBP Psychosocial
No baby day Positive state or trait
 Base −0.32* −0.27  Mastery + 0.33**
 Prep −0.29* −0.42**  Total ISEL support + 0.40**
 Speech −0.09 −0.11  Dyadic adjustment + 0.18
 Replay −0.42** −0.41**
Baby day Negative state or trait
 Base −0.26 −0.29*  Depression −0.20
 Prep −0.29* −0.17  State anxiety −0.12
 Speech −0.23 −0.02  Trait anxiety −0.25
 Replay −0.24 −0.12  Anger-in −0.02
Ambulatory  Anger-out −0.11
 Wake −0.22 −0.17  Perceived stress −0.23
 Feed −0.35** −0.25  Daily stress + 0.06
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